Cargando…
The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia
BACKGROUND/AIM: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients. MATERIALS AND METHODS: Between May a...
Autores principales: | ESATOĞLU, Sinem Nihal, KESKİN, Dilek, EŞKAZAN, Ahmet Emre, ELVERDİ, Tuğrul, SALİHOĞLU, Ayşe, AR, Muhlis Cem, ÖNGÖREN, Şeniz, BAŞLAR, Zafer, AYDIN, Yıldız, UZUN, Hafize, SOYSAL, Teoman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991891/ https://www.ncbi.nlm.nih.gov/pubmed/32950049 http://dx.doi.org/10.3906/sag-2004-282 |
Ejemplares similares
-
Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience
por: Öngören, Şeniz, et al.
Publicado: (2017) -
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience
por: Öngören, Seniz, et al.
Publicado: (2018) -
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
por: Çokgezer, Simay, et al.
Publicado: (2022) -
Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options
por: Çetin, Güven, et al.
Publicado: (2014) -
The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience
por: Kucukyurt, Selin, et al.
Publicado: (2021)